-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS INC - KT-621 ACHIEVES 94% AND 98% STAT6 DEGRADATION IN SKIN AND BLOOD

Reuters·12/08/2025 12:00:02

Please log in to view news